CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-21 | Dayno Jeffrey M. PRESIDENT, CEO | Option exercise 10b5-1 | +19,293 | $8.22 | $159K | 19,293 |
| 2025-01-21 | Dayno Jeffrey M. PRESIDENT, CEO | Sale 10b5-1 | −19,293 | $40.13 | $774K | 0 |
| 2025-01-21 | Dayno Jeffrey M. PRESIDENT, CEO | Option exercise · Stock Option 10b5-1 | −3,470 | 20,000 | ||
| 2025-01-21 | Dayno Jeffrey M. PRESIDENT, CEO | Option exercise · Stock Option 10b5-1 | −6,086 | 0 | ||
| 2025-01-21 | Dayno Jeffrey M. PRESIDENT, CEO | Option exercise · Stock Option 10b5-1 | −9,737 | 2,435 | ||
| 2025-01-21 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +25,000 | $29.03 | $726K | 25,000 |
| 2025-01-21 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −25,000 | $40.18 | $1.0M | 0 |
| 2025-01-21 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −25,000 | 205,000 | ||
| 2025-01-21 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +1,123 | $33.44 | $38K | 1,123 |
| 2025-01-21 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,123 | $40.00 | $45K | 0 |
| 2025-01-21 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −1,123 | 5,615 | ||
| 2025-01-16 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +29,475 | $33.44 | $986K | 29,475 |
| 2025-01-16 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −29,475 | $37.41 | $1.1M | 0 |
| 2025-01-16 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −29,475 | 6,738 | ||
| 2025-01-15 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +10,507 | $33.44 | $351K | 10,507 |
| 2025-01-15 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −10,507 | $37.01 | $389K | 0 |
| 2025-01-15 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −10,507 | 36,213 | ||
| 2025-01-13 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +7,180 | $33.44 | $240K | 7,180 |
| 2025-01-13 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −7,180 | $37.04 | $266K | 0 |
| 2025-01-13 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −7,180 | 46,720 |
Page 8 of 14 · 268 trades